FDA permanently revokes Dengvaxia registration – ABS-CBN News

MANILA – The Food and Drug Administration has permanently revoked the certificate of product registration (CPR) of anti-dengue vaccine Dengvaxia, which has been blamed for a slump in immunization rates. The previous Aquino administration inoculated hundreds of thousands of schoolchildren with the world’s first dengue vaccine. French drug maker Sanofi, however, disclosed in December 2017 that the vaccine can trigger more severe symptoms for those who have not had dengue, prompting the government to stop the sale of Dengvaxia and its use in the state immunization drive. Dengvaxia’s product registration was scrapped due to Sanofi’s persistent failure to submit post-approval ...

Gepostet in der Kategorie Lebensweise (Anzahl der ansichten:) 3